- As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman
- Robert A. Michael Joins AbbVie Board of Directors
NORTH CHICAGO, Ill., July 1, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors, effective today. As previously announced, Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company's inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.